Wednesday, July 11, 2012 8:53:31 AM
http://www.sec.gov/litigation/litreleases/2012/lr22412.htm
U.S. SECURITIES AND EXCHANGE COMMISSION
Litigation Release No. 22412 /July 11, 2012
Securities and Exchange Commission v. Orthofix International N.V., United States District Court for the Eastern District of Texas, Case No. 4:12-CV-419 (filed July 10, 2012)
SEC CHARGES ORTHOFIX INTERNATIONAL WITH FCPA VIOLATIONS
The Securities and Exchange Commission today charged Texas-based medical device company Orthofix International N.V. with violating the Foreign Corrupt Practices Act (FCPA) when a subsidiary paid routine bribes referred to as “chocolates” to Mexican officials in order to obtain lucrative sales contracts with government hospitals.
The SEC alleges that Orthofix’s Mexican subsidiary Promeca S.A. de C.V. bribed officials at Mexico’s government-owned health care and social services institution Instituto Mexicano del Seguro Social (IMSS). The “chocolates” came in the form of cash, laptop computers, televisions, and appliances that were provided directly to Mexican government officials or indirectly through front companies that the officials owned. The bribery scheme lasted for several years and yielded nearly $5 million in illegal profits for the Orthofix subsidiary.
Orthofix agreed to pay $5.2 million to settle the SEC’s charges.
According to the SEC’s complaint filed in U.S. District Court for the Eastern District of Texas, the bribes began in 2003 and continued until 2010. Initially, Promeca falsely recorded the bribes as cash advances and falsified its invoices to support the expenditures. Later, when the bribes got much larger, Promeca falsely recorded them as promotional and training costs. Because of the bribery scheme, Promeca’s training and promotional expenses were significantly over budget. Orthofix did launch an inquiry into these expenses, but did very little to investigate or diminish the excessive spending. Later, upon discovery of the bribe payments through a Promeca executive, Orthofix immediately self-reported the matter to the SEC and implemented significant remedial measures. The company terminated the Promeca executives who orchestrated the bribery scheme.
The SEC’s proposed settlement is subject to court approval. Orthofix consented to a final judgment ordering it to pay $4,983,644 in disgorgement and more than $242,000 in prejudgment interest. The final judgment would permanently enjoined the company from violating Sections 13(b)(2)(A) and 13(b)(2)(B) of the Securities Exchange Act of 1934. Orthofix also agreed to certain undertakings, including monitoring its FCPA compliance program and reporting back to the SEC for a two-year period.
Orthofix also disclosed today in an 8-K filing that it has reached an agreement with the U.S. Department of Justice to pay a $2.22 million penalty in a related action.
The SEC’s investigation was conducted by Carol Shau and Alka N. Patel in the Los Angeles Regional Office. The SEC acknowledges and appreciates the assistance of the U.S. Department of Justice’s Criminal Division-Fraud Section and the Federal Bureau of Investigation.
SEC Complaint:
http://www.sec.gov/litigation/complaints/2012/comp22412.pdf
To bite the worm of incite is to bite the HOOK of the antagonist . They win .
Recent OFIX News
- Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX • PR Newswire (US) • 09/19/2024 09:45:00 AM
- Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX • PR Newswire (US) • 09/19/2024 09:45:00 AM
- Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX • PR Newswire (US) • 09/16/2024 09:45:00 AM
- Orthofix Medical Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX • PR Newswire (US) • 09/16/2024 09:45:00 AM
- Shareholders of Orthofix Medical Inc. Should Contact The Gross Law Firm Before October 21, 2024 to Discuss Your Rights - OFIX • PR Newswire (US) • 09/12/2024 09:45:00 AM
- Shareholders that lost money on Orthofix Medical Inc.(OFIX) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 09/09/2024 02:20:00 PM
- The Gross Law Firm Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - OFIX • PR Newswire (US) • 09/05/2024 09:45:00 AM
- The Gross Law Firm Reminds Orthofix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - OFIX • PR Newswire (US) • 09/05/2024 09:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:25:14 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:20:11 PM
- Patrick Fisher Joins Orthofix as President of Global Orthopedics Business • Business Wire • 08/15/2024 09:52:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/15/2024 09:19:14 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/15/2024 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 11:08:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:06:38 AM
- Orthofix Reports Second Quarter 2024 Results and Raises Full-Year 2024 Financial Guidance • Business Wire • 08/06/2024 11:03:00 AM
- Orthofix to Participate in Canaccord Genuity's 44th Annual Growth Conference • Business Wire • 07/17/2024 11:00:00 AM
- Orthofix Names Stephanie Walsh Chief Human Resources Officer • Business Wire • 07/16/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/15/2024 09:11:43 PM
- Orthofix Announces 510(k) Clearance and First Implant of Fitbone Transport and Lengthening System • Business Wire • 07/09/2024 11:00:00 AM
- Orthofix to Report Second Quarter 2024 Financial Results • Business Wire • 07/09/2024 11:00:00 AM
- Michael Finegan Named Chair of the Orthofix Board of Directors • Business Wire • 06/24/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 11:07:28 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 11:06:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2024 11:06:08 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM